Skip to main content
. 2017 Dec 6;7:17056. doi: 10.1038/s41598-017-17316-y

Figure 1.

Figure 1

Reduction of N/P of PF14/pDNA allows neutralization of the surface charge and reduction of opsonization of the particles. (a) The average size and zeta potential of PF14/pDNA complexes at decreasing N/P was evaluated using DLS. (b) Membrane disturbing activities of PF14 peptide and PF14/pDNA complexes are assessed through the hemolysis assay, where the liberation of hemoglobin from mouse RBCs is used as a measure of “membrane activity”. Data is represented as hemolysis %, where 100% represents hemolysis of all cells (Triton X-100) and 0% represents treatment with a neutral solution (5% glucose). (c) Opsonization of the PF14/pDNA nanoparticles with FBS. The nanoparticles were incubated in serum, separated, and quantitated after SDS-PAGE. The nanoparticle-associated total protein amount is expressed in arbitrary units. The values are the means of two experiments.